NEU 2.82% $14.15 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1034

  1. 390 Posts.
    lightbulb Created with Sketch. 15
    It’s worth nothing. That is an entirely useless AI generated article that doesn’t mention anything NEU is actually doing such as well you know…medical trials. It just regurgitates data like EPS into paragraphs and compares pointless things like CEO salary for similar sized market caps.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.